CD19 and acute lymphoblastic leukemia: Gardner et al. [128] showed that CD19 CAR-T-cell treatment results in the relapse of CD19-negative acute myeloid leukemia in B-ALL patients with mixed leukemia gene rearrangement and reported lineage switching with CAR-T-cell selection pressure.